Kite Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Kite Pharma and buy or sell other stocks, ETFs, and their options commission-free!About KITE
Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers.
CEOArie S. Belldegrun, MD
CEOArie S. Belldegrun, MD
Employees—
Employees—
HeadquartersSanta Monica, California
HeadquartersSanta Monica, California
Founded2009
Founded2009
Employees—
Employees—
KITE Key Statistics
Market cap10.26B
Market cap10.26B
Price-Earnings ratio-26.17
Price-Earnings ratio-26.17
Dividend yield—
Dividend yield—
Average volume1.77M
Average volume1.77M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$179.95
52 Week high$179.95
52 Week low$39.82
52 Week low$39.82
Stock Snapshot
The current Kite Pharma(KITE) stock price is $179.79, with a market capitalization of 10.26B. The stock trades at a price-to-earnings (P/E) ratio of -26.17.
On 2025-12-14, Kite Pharma(KITE) stock opened at —, reached a high of —, and a low of —.
The Kite Pharma(KITE)'s current trading volume is 0, compared to an average daily volume of 1.77M.
In the last year, Kite Pharma(KITE) shares hit a 52-week high of $179.95 and a 52-week low of $39.82.
In the last year, Kite Pharma(KITE) shares hit a 52-week high of $179.95 and a 52-week low of $39.82.